Prohibited Transaction Claims Survive In ERISA Suit Over Prescription Costs

( March 10, 2026, 11:37 AM EDT) -- NEW YORK — After two similar putative class actions filed under the Employee Retirement Income Security Act in other jurisdictions were dismissed for lack of standing, a New York federal judge on March 9 ruled that plaintiffs who sued JPMorgan Chase & Co. and related entities over purported mismanagement of a prescription drug program have standing but sufficiently stated only their prohibited transaction claims....

Attached Documents

Related Sections